Desq Long
Sign in

Company

Roivant Sciences Ltd.

ROIV · CIK 0001635088

SEC FORM 4
$154,307.60

Roivant Sciences Ltd. (ROIV)

Disposition (code F) of 3,880 shares at $39.77 per share.

Reporting Person Humes Jennifer · Officer Title Chief Accounting Officer · Transaction Code F

Traded Sep 20, 2026 · Disclosed Sep 22, 2026

Source: SEC Form 4 · 0001140361-26-037363 · filed 2026-09-22 · View filing →

SEC FORM 4
$84,670.33

Roivant Sciences Ltd. (ROIV)

Disposition (code F) of 2,129 shares at $39.77 per share.

Reporting Person Pulik Richard · Officer Title CFO · Transaction Code F

Traded Sep 20, 2026 · Disclosed Sep 22, 2026

Source: SEC Form 4 · 0001635088-26-000104 · filed 2026-09-22 · View filing →

SEC FORM 4
$0.00

Roivant Sciences Ltd. (ROIV)

Acquisition (code A) of 5,054 shares at $0 per share.

Reporting Person MANCHESTER KEITH S · Transaction Code A

Traded Sep 16, 2026 · Disclosed Sep 18, 2026

Source: SEC Form 4 · 0001140361-26-037158 · filed 2026-09-18 · View filing →

SEC FORM 4
$0.00

Roivant Sciences Ltd. (ROIV)

Acquisition (code A) of 5,054 shares at $0 per share.

Reporting Person MOMTAZEE JAMES C · Transaction Code A

Traded Sep 16, 2026 · Disclosed Sep 18, 2026

Source: SEC Form 4 · 0001209181-26-000007 · filed 2026-09-18 · View filing →

SEC FORM 4
$0.00

Roivant Sciences Ltd. (ROIV)

Acquisition (code A) of 5,054 shares at $0 per share.

Reporting Person Fitzgerald Meghan · Transaction Code A

Traded Sep 16, 2026 · Disclosed Sep 18, 2026

Source: SEC Form 4 · 0001349297-26-000010 · filed 2026-09-18 · View filing →

SEC FORM 4
$0.00

Roivant Sciences Ltd. (ROIV)

Acquisition (code A) of 5,054 shares at $0 per share.

Reporting Person Oren Ilan · Transaction Code A

Traded Sep 16, 2026 · Disclosed Sep 18, 2026

Source: SEC Form 4 · 0001635088-26-000099 · filed 2026-09-18 · View filing →

SEC FORM 4
$0.00

Roivant Sciences Ltd. (ROIV)

Acquisition (code A) of 5,054 shares at $0 per share.

Reporting Person Gold Daniel Allen · Transaction Code A

Traded Sep 16, 2026 · Disclosed Sep 18, 2026

Source: SEC Form 4 · 0001635088-26-000102 · filed 2026-09-18 · View filing →

SEC FORM 4
$0.00

Roivant Sciences Ltd. (ROIV)

Acquisition (code A) of 5,054 shares at $0 per share.

Reporting Person Epperly Melissa B, · Transaction Code A

Traded Sep 16, 2026 · Disclosed Sep 18, 2026

Source: SEC Form 4 · 0001807359-26-000016 · filed 2026-09-18 · View filing →

SEC FORM 4
$186,972.16

Roivant Sciences Ltd. (ROIV)

Sale of 4,712 shares at $39.68 per share.

Reporting Person Fitzgerald Meghan · Transaction Code S

Traded Sep 15, 2026 · Disclosed Sep 17, 2026

Source: SEC Form 4 · 0001349297-26-000008 · filed 2026-09-17 · View filing →

SEC FORM 4
$16,180.00

Roivant Sciences Ltd. (ROIV)

Sale of 400 shares at $40.45 per share.

Reporting Person Fitzgerald Meghan · Transaction Code S

Traded Sep 15, 2026 · Disclosed Sep 17, 2026

Source: SEC Form 4 · 0001349297-26-000008 · filed 2026-09-17 · View filing →

SEC FORM 4
$172,001.70

Roivant Sciences Ltd. (ROIV)

Sale of 4,338 shares at $39.65 per share.

Reporting Person Epperly Melissa B, · Transaction Code S

Traded Sep 15, 2026 · Disclosed Sep 17, 2026

Source: SEC Form 4 · 0001807359-26-000014 · filed 2026-09-17 · View filing →

SEC FORM 4
$24,228.00

Roivant Sciences Ltd. (ROIV)

Sale of 600 shares at $40.38 per share.

Reporting Person Epperly Melissa B, · Transaction Code S

Traded Sep 15, 2026 · Disclosed Sep 17, 2026

Source: SEC Form 4 · 0001807359-26-000014 · filed 2026-09-17 · View filing →

SEC FORM 4
$210,145.02

Roivant Sciences Ltd. (ROIV)

Disposition (code F) of 5,133 shares at $40.94 per share.

Reporting Person Gold Daniel Allen · Transaction Code F

Traded Sep 10, 2026 · Disclosed Sep 14, 2026

Source: SEC Form 4 · 0001140361-26-036535 · filed 2026-09-14 · View filing →

SEC FORM 4
$118,930.70

Roivant Sciences Ltd. (ROIV)

Disposition (code F) of 2,905 shares at $40.94 per share.

Reporting Person MOMTAZEE JAMES C · Transaction Code F

Traded Sep 10, 2026 · Disclosed Sep 14, 2026

Source: SEC Form 4 · 0001209181-26-000005 · filed 2026-09-14 · View filing →

SEC FORM 4
$71,358.42

Roivant Sciences Ltd. (ROIV)

Disposition (code F) of 1,743 shares at $40.94 per share.

Reporting Person Fitzgerald Meghan · Transaction Code F

Traded Sep 10, 2026 · Disclosed Sep 14, 2026

Source: SEC Form 4 · 0001349297-26-000006 · filed 2026-09-14 · View filing →

SEC FORM 4
$97,355.32

Roivant Sciences Ltd. (ROIV)

Disposition (code F) of 2,378 shares at $40.94 per share.

Reporting Person Oren Ilan · Transaction Code F

Traded Sep 10, 2026 · Disclosed Sep 14, 2026

Source: SEC Form 4 · 0001635088-26-000092 · filed 2026-09-14 · View filing →

SEC FORM 4
$89,208.26

Roivant Sciences Ltd. (ROIV)

Disposition (code F) of 2,179 shares at $40.94 per share.

Reporting Person Epperly Melissa B, · Transaction Code F

Traded Sep 10, 2026 · Disclosed Sep 14, 2026

Source: SEC Form 4 · 0001807359-26-000012 · filed 2026-09-14 · View filing →

SEC FORM 4
$176,000.00

Roivant Sciences Ltd. (ROIV)

Acquisition (code M) of 20,000 shares at $8.8 per share.

Reporting Person Fitzgerald Meghan · Transaction Code M

Traded Sep 8, 2026 · Disclosed Sep 10, 2026

Source: SEC Form 4 · 0001140361-26-036246 · filed 2026-09-10 · View filing →

SEC FORM 4
$798,000.00

Roivant Sciences Ltd. (ROIV)

Sale of 20,000 shares at $39.9 per share.

Reporting Person Fitzgerald Meghan · Transaction Code S

Traded Sep 8, 2026 · Disclosed Sep 10, 2026

Source: SEC Form 4 · 0001140361-26-036246 · filed 2026-09-10 · View filing →

SEC FORM 4
$770,000.00

Roivant Sciences Ltd. (ROIV)

Acquisition (code M) of 200,000 shares at $3.85 per share.

Reporting Person Venker Eric · Officer Title President & Immunovant CEO · Transaction Code M

Traded Aug 28, 2026 · Disclosed Sep 1, 2026

Source: SEC Form 4 · 0001140361-26-035375 · filed 2026-09-01 · View filing →

SEC FORM 4
$5,921,064.66

Roivant Sciences Ltd. (ROIV)

Sale of 166,182 shares at $35.63 per share.

Reporting Person Venker Eric · Officer Title President & Immunovant CEO · Transaction Code S

Traded Aug 28, 2026 · Disclosed Sep 1, 2026

Source: SEC Form 4 · 0001140361-26-035375 · filed 2026-09-01 · View filing →

SEC FORM 4
$1,232,327.92

Roivant Sciences Ltd. (ROIV)

Sale of 33,818 shares at $36.44 per share.

Reporting Person Venker Eric · Officer Title President & Immunovant CEO · Transaction Code S

Traded Aug 28, 2026 · Disclosed Sep 1, 2026

Source: SEC Form 4 · 0001140361-26-035375 · filed 2026-09-01 · View filing →

SEC FORM 4
$512,407.56

Roivant Sciences Ltd. (ROIV)

Disposition (code F) of 13,909 shares at $36.84 per share.

Reporting Person Venker Eric · Officer Title President & Immunovant CEO · Transaction Code F

Traded Aug 20, 2026 · Disclosed Aug 24, 2026

Source: SEC Form 4 · 0001140361-26-034238 · filed 2026-08-24 · View filing →

SEC FORM 4
$211,793.16

Roivant Sciences Ltd. (ROIV)

Disposition (code F) of 5,749 shares at $36.84 per share.

Reporting Person Pulik Richard · Officer Title CFO · Transaction Code F

Traded Aug 20, 2026 · Disclosed Aug 24, 2026

Source: SEC Form 4 · 0001140361-26-034239 · filed 2026-08-24 · View filing →

SEC FORM 4
$557,310.60

Roivant Sciences Ltd. (ROIV)

Acquisition (code M) of 144,756 shares at $3.85 per share.

Reporting Person Sukhatme Mayukh · Officer Title President & CIO · Transaction Code M

Traded Aug 21, 2026 · Disclosed Aug 21, 2026

Source: SEC Form 4 · 0001140361-26-034066 · filed 2026-08-21 · View filing →

SEC FORM 4
$5,280,698.88

Roivant Sciences Ltd. (ROIV)

Sale of 144,756 shares at $36.48 per share.

Reporting Person Sukhatme Mayukh · Officer Title President & CIO · Transaction Code S

Traded Aug 21, 2026 · Disclosed Aug 21, 2026

Source: SEC Form 4 · 0001140361-26-034066 · filed 2026-08-21 · View filing →

SEC FORM 4
$67,448.15

Roivant Sciences Ltd. (ROIV)

Acquisition (code M) of 17,519 shares at $3.85 per share.

Reporting Person Sukhatme Mayukh · Officer Title President & CIO · Transaction Code M

Traded Aug 20, 2026 · Disclosed Aug 21, 2026

Source: SEC Form 4 · 0001140361-26-034066 · filed 2026-08-21 · View filing →

SEC FORM 4
$653,458.70

Roivant Sciences Ltd. (ROIV)

Sale of 17,519 shares at $37.3 per share.

Reporting Person Sukhatme Mayukh · Officer Title President & CIO · Transaction Code S

Traded Aug 20, 2026 · Disclosed Aug 21, 2026

Source: SEC Form 4 · 0001140361-26-034066 · filed 2026-08-21 · View filing →

SEC FORM 4
$665,661.15

Roivant Sciences Ltd. (ROIV)

Acquisition (code M) of 172,899 shares at $3.85 per share.

Reporting Person Sukhatme Mayukh · Officer Title President & CIO · Transaction Code M

Traded Aug 19, 2026 · Disclosed Aug 21, 2026

Source: SEC Form 4 · 0001140361-26-034066 · filed 2026-08-21 · View filing →

SEC FORM 4
$6,426,655.83

Roivant Sciences Ltd. (ROIV)

Sale of 172,899 shares at $37.17 per share.

Reporting Person Sukhatme Mayukh · Officer Title President & CIO · Transaction Code S

Traded Aug 19, 2026 · Disclosed Aug 21, 2026

Source: SEC Form 4 · 0001140361-26-034066 · filed 2026-08-21 · View filing →

SEC FORM 4
$404,792.85

Roivant Sciences Ltd. (ROIV)

Acquisition (code M) of 105,141 shares at $3.85 per share.

Reporting Person Sukhatme Mayukh · Officer Title President & CIO · Transaction Code M

Traded Aug 18, 2026 · Disclosed Aug 18, 2026

Source: SEC Form 4 · 0001140361-26-033637 · filed 2026-08-18 · View filing →

SEC FORM 4
$3,847,109.19

Roivant Sciences Ltd. (ROIV)

Sale of 105,141 shares at $36.59 per share.

Reporting Person Sukhatme Mayukh · Officer Title President & CIO · Transaction Code S

Traded Aug 18, 2026 · Disclosed Aug 18, 2026

Source: SEC Form 4 · 0001140361-26-033637 · filed 2026-08-18 · View filing →

SEC FORM 4
$122,433.85

Roivant Sciences Ltd. (ROIV)

Acquisition (code M) of 31,801 shares at $3.85 per share.

Reporting Person Sukhatme Mayukh · Officer Title President & CIO · Transaction Code M

Traded Aug 18, 2026 · Disclosed Aug 18, 2026

Source: SEC Form 4 · 0001140361-26-033637 · filed 2026-08-18 · View filing →

SEC FORM 4
$1,182,361.18

Roivant Sciences Ltd. (ROIV)

Sale of 31,801 shares at $37.18 per share.

Reporting Person Sukhatme Mayukh · Officer Title President & CIO · Transaction Code S

Traded Aug 18, 2026 · Disclosed Aug 18, 2026

Source: SEC Form 4 · 0001140361-26-033637 · filed 2026-08-18 · View filing →

SEC FORM 4
$1,096,121.95

Roivant Sciences Ltd. (ROIV)

Acquisition (code M) of 284,707 shares at $3.85 per share.

Reporting Person Sukhatme Mayukh · Officer Title President & CIO · Transaction Code M

Traded Aug 17, 2026 · Disclosed Aug 18, 2026

Source: SEC Form 4 · 0001140361-26-033637 · filed 2026-08-18 · View filing →

SEC FORM 4
$10,320,628.75

Roivant Sciences Ltd. (ROIV)

Sale of 284,707 shares at $36.25 per share.

Reporting Person Sukhatme Mayukh · Officer Title President & CIO · Transaction Code S

Traded Aug 17, 2026 · Disclosed Aug 18, 2026

Source: SEC Form 4 · 0001140361-26-033637 · filed 2026-08-18 · View filing →

SEC FORM 4
$936,231.45

Roivant Sciences Ltd. (ROIV)

Acquisition (code M) of 243,177 shares at $3.85 per share.

Reporting Person Sukhatme Mayukh · Officer Title President & CIO · Transaction Code M

Traded Aug 14, 2026 · Disclosed Aug 18, 2026

Source: SEC Form 4 · 0001140361-26-033637 · filed 2026-08-18 · View filing →

SEC FORM 4
$8,810,302.71

Roivant Sciences Ltd. (ROIV)

Sale of 243,177 shares at $36.23 per share.

Reporting Person Sukhatme Mayukh · Officer Title President & CIO · Transaction Code S

Traded Aug 14, 2026 · Disclosed Aug 18, 2026

Source: SEC Form 4 · 0001140361-26-033637 · filed 2026-08-18 · View filing →